At the news
? NEUTRALIMPACT 2/10 CLUSTER filed Mar 9, 2026 at 20:00 ET
A single insider sale occurred at Stoke Therapeutics, with Director Arthur A. Levin selling 605 shares for $22,264 in the past week. This transaction is part of a broader pattern of recent insider selling, with four sales totaling $1.8 million over the last 30 days. The activity represents minimal economic impact relative to the company's $1.9B market cap.
- Director Arthur A. Levin sold 605 shares at $36.80 per share for a total of $22,264
- Transaction was an open-market sale (Form 4 code 'S')
- Part of a cluster of 4 insider sales totaling $1.8M over the past 30 days
- Total recent insider selling ($1.8M) represents only 0.09% of the company's $1.9B market cap
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access